Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage... Show more
a provider of automation, vacuum and instrumentation solutions
Industry PharmaceuticalsOther
A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with IQV. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then IQV could also see price increases.
| Ticker / NAME | Correlation To AZTA | 1D Price Change % | ||
|---|---|---|---|---|
| AZTA | 100% | +12.38% | ||
| IQV - AZTA | 60% Loosely correlated | -0.96% | ||
| RVTY - AZTA | 59% Loosely correlated | +1.66% | ||
| A - AZTA | 59% Loosely correlated | +0.66% | ||
| MTD - AZTA | 59% Loosely correlated | +0.34% | ||
| BRKR - AZTA | 58% Loosely correlated | +2.10% | ||
More | ||||
| Ticker / NAME | Correlation To AZTA | 1D Price Change % |
|---|---|---|
| AZTA | 100% | +12.38% |
| Pharmaceuticals: Other industry (50 stocks) | 42% Loosely correlated | -0.60% |
| Pharmaceuticals industry (154 stocks) | 2% Poorly correlated | -0.72% |
AZTA saw its Momentum Indicator move above the 0 level on September 15, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In 64 of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at 76%.
The Moving Average Convergence Divergence (MACD) for AZTA just turned positive on September 17, 2026. Looking at past instances where AZTA's MACD turned positive, the stock continued to rise in 37 of 49 cases over the following month. The odds of a continued upward trend are 76%.
Following a +1.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where AZTA advanced for three days, in 216 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AZTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
AZTA broke above its upper Bollinger Band on October 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AZTA entered a downward trend on September 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. AZTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.994) is normal, around the industry mean (5.011). P/E Ratio (42.431) is within average values for comparable stocks, (163.451). Projected Growth (PEG Ratio) (0.310) is also within normal values, averaging (4.456). Dividend Yield (0.002) settles around the average of (0.005) among similar stocks. P/S Ratio (2.485) is also within normal values, averaging (56.074).
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AZTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.